NO891707L - Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske nitrometanderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske nitrometanderivater.

Info

Publication number
NO891707L
NO891707L NO89891707A NO891707A NO891707L NO 891707 L NO891707 L NO 891707L NO 89891707 A NO89891707 A NO 89891707A NO 891707 A NO891707 A NO 891707A NO 891707 L NO891707 L NO 891707L
Authority
NO
Norway
Prior art keywords
derivatives
nitrometan
procedure
preparation
therapeutic active
Prior art date
Application number
NO89891707A
Other languages
English (en)
Norwegian (no)
Other versions
NO891707D0 (no
Inventor
Steven Paul Brown
Anthony Loren Cooper
Jethro Lawrence Longridge
Jeffrey James Morris
John Preston
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO891707D0 publication Critical patent/NO891707D0/no
Publication of NO891707L publication Critical patent/NO891707L/no

Links

Classifications

    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10B—ORGANS, HARMONIUMS OR SIMILAR WIND MUSICAL INSTRUMENTS WITH ASSOCIATED BLOWING APPARATUS
    • G10B3/00—Details or accessories
    • G10B3/12—Keys or keyboards; Manuals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/76—Dibenzothiophenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Multimedia (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Air Bags (AREA)
  • Detergent Compositions (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO89891707A 1988-04-29 1989-04-25 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske nitrometanderivater. NO891707L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888810203A GB8810203D0 (en) 1988-04-29 1988-04-29 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
NO891707D0 NO891707D0 (no) 1989-04-25
NO891707L true NO891707L (no) 1989-10-30

Family

ID=10636116

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891707A NO891707L (no) 1988-04-29 1989-04-25 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske nitrometanderivater.

Country Status (20)

Country Link
US (1) US5102905A (zh)
EP (1) EP0340010B1 (zh)
JP (1) JPH01316355A (zh)
KR (1) KR900016937A (zh)
CN (1) CN1037339A (zh)
AT (1) ATE110378T1 (zh)
AU (1) AU623128B2 (zh)
DD (1) DD283817A5 (zh)
DE (1) DE68917634D1 (zh)
DK (1) DK200889A (zh)
FI (1) FI892038A (zh)
GB (2) GB8810203D0 (zh)
HU (1) HUT49868A (zh)
MW (1) MW1389A1 (zh)
NO (1) NO891707L (zh)
NZ (1) NZ228915A (zh)
PT (1) PT90395B (zh)
ZA (1) ZA892597B (zh)
ZM (1) ZM1889A1 (zh)
ZW (1) ZW5989A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL93178A0 (en) * 1989-02-03 1990-11-05 Ici Plc Benzheterocyclyl sulphones
GB9016978D0 (en) * 1990-08-02 1990-09-19 Ici Plc Acetamide derivatives
US5250570A (en) * 1990-08-02 1993-10-05 Imperial Chemical Industries Plc Amidobenzene derivatives, compositions and use
WO1994007867A1 (en) * 1992-09-28 1994-04-14 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
CA2195850A1 (en) * 1994-08-03 1996-02-15 Guillaume Lebaut Substituted indoles
DE69523182T2 (de) * 1995-06-06 2002-02-07 Pfizer Substituierte n-(indol-2-carbonyl)-glycinamide und derivate als glycogen phosphorylase inhibitoren
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
CN110551015B (zh) * 2018-05-31 2022-06-21 株式会社Lg化学 化合物及利用其的有机发光元件
KR102229001B1 (ko) * 2018-05-31 2021-03-17 주식회사 엘지화학 신규한 화합물 및 이를 이용한 유기 발광 소자

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053633A (en) * 1976-06-24 1977-10-11 The Dow Chemical Company Aryl dibromonitromethyl sulfones
US4670470A (en) * 1979-08-15 1987-06-02 Merck & Co., Inc. Allylsulfoxide enzyme inhibitors
US4309554A (en) * 1980-04-28 1982-01-05 The Dow Chemical Company 3-(2-Thiophenesulfonyl)-2-halopropanenitriles
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
DD216237A1 (de) * 1983-06-23 1984-12-05 Univ Halle Wittenberg Verfahren zur herstellung von substituierten 4-phenyl-thiophenen
DE3768352D1 (de) * 1986-06-30 1991-04-11 Merck & Co Inc Alkansulfonamide als antiglaucoma-mittel.
GB8718619D0 (en) * 1987-08-06 1987-09-09 Ici Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
DK200889D0 (da) 1989-04-25
FI892038A (fi) 1989-10-30
DD283817A5 (de) 1990-10-24
KR900016937A (ko) 1990-11-14
DK200889A (da) 1989-10-30
EP0340010A2 (en) 1989-11-02
EP0340010A3 (en) 1991-05-15
MW1389A1 (en) 1989-12-13
AU3308089A (en) 1989-11-02
PT90395A (pt) 1989-11-10
FI892038A0 (fi) 1989-04-28
HUT49868A (en) 1989-11-28
JPH01316355A (ja) 1989-12-21
AU623128B2 (en) 1992-05-07
GB8810203D0 (en) 1988-06-02
DE68917634D1 (de) 1994-09-29
ZA892597B (en) 1989-12-27
PT90395B (pt) 1995-03-31
ZW5989A1 (en) 1990-01-03
ZM1889A1 (en) 1990-01-26
ATE110378T1 (de) 1994-09-15
NZ228915A (en) 1991-12-23
NO891707D0 (no) 1989-04-25
US5102905A (en) 1992-04-07
EP0340010B1 (en) 1994-08-24
CN1037339A (zh) 1989-11-22
GB8906822D0 (en) 1989-05-10

Similar Documents

Publication Publication Date Title
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
IE781878L (en) Imidazole derivatives
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
NO891707L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske nitrometanderivater.
MY103595A (en) (arylsulphonyl) nitromethanes, process for their preparation and use in pharmaceutical compositions
NO168243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO301826B1 (no) Heterotricyklisk substituerte fenylcykloheksankarboksylsyrederivater, legemidler inneholdende dem og deres anvendelse for fremstilling av legemidler
ATE133161T1 (de) (p-carbonylaminophenyl)- sulphonylnitromethanderivate
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
NO173822C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (4-amino-2,6-dimetylfenylsulfonyl)nitrometan og farmasoeytisk akseptable salter derav
AU2013888A (en) Uricosuric composition
ATE112263T1 (de) Amidobenzole.
AU553765B2 (en) Biologically active heterocyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof